Skip to main content
Home
  • Get Care
    • Find a Doctor
    • Request an Appointment
    • Virtual Visits
    • Locations & Directions
    • News
    • About Columbia Surgery
    • All Resources
  • Surgical Specialties
      • Adrenal
      • Aorta
      • Breast
      • Colorectal
      • Colorectal (Global Center)
      • Esophageal
      • Gall Bladder & Appendix
      • Gastric Cancer
      • Heart (Adult)
      • Heart (Pediatric)
      • Hernia
      • Kidney/Pancreas Transplantation
      • Liver Transplantation
      • Lung & Chest
      • Melanoma
      • Pancreas
      • Parathyroid
      • Pediatric/Neonatal
      • Plastic & Reconstructive
      • Robotic Surgery
      • Sarcoma
      • Thyroid
      • Vascular
      • Weight Loss Surgery
    • All Specialties
  • Research & Trials
    • About Research
    • About Clinical Trials
    • Basic & Translational Research
    • Cardiovascular Research
    • Clinical Research
    • Innovation & Outcomes Research
    • Translational Immunology Research
    • Transplant Research
    • All Research & Trials
  • Conditions & Treatments
      • Adrenal
      • Aortic
      • Breast
      • Colorectal
      • Esophageal
      • Gallbladder & Appendix (General Surgery)
      • Heart (Adult)
      • Hernia
      • Kidney
      • Liver
      • Lung & Chest (Thoracic)
      • Pancreas
      • Parathyroid
      • Pediatric (Neonatal)
      • Plastics (Cosmetic & Reconstructive)
      • Skin
      • Stomach (Gastric)
      • Thyroid
      • Vascular
      • Weight Loss (Bariatric)
    • All Conditions and Treatments
  • For Students and Professionals
  • Ways to Help
  • Request an Appointment

Search results

A Phase 3, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed-Dose Combination in Subjects with Chronic HCV Infection and Child-Pugh Class B Cirrhosis

… (RBV) for 12 weeks and SOF/GS-5816 FDC for 24 weeks in adults with hepatitis C virus (HCV) infection and … and Safety of Sofosbuvir/GS-5816 Fixed-Dose Combination in Subjects with Chronic HCV Infection and Child-Pugh Class B …

Last Modified: 02/13/2023 - 21:06

A Phase Ib/2, Multicenter, Open-label Trial to Evaluate the Safety and Efficacy of Talimogene Laherparepvec and Ipilimumab Compared to Ipilimumab Alone in Subjects with Previously Untreated, Unresected, Stage IIIB-IV Melanoma

… laherparepvec (formerly known as OncoVEXGM-CSF), in people with advanced melanoma when given in combination with another drug called ipilimumab. Melanoma … to other parts of the body. The study will be conducted in two parts. Phase 1 of the study will see if talimogene …

Last Modified: 02/13/2023 - 21:06

A randomized, parallel-group, double-blind, placebo-controlled, multi-center study of eculizumab for the prevention of delayed graft function after kidney transplantation in adult subjects at increased risk of delayed graft function.

… safety of a two dose regimen of eculizumab to prevent DGF in adult patients undergoing deceased-donor kidney … of delayed graft function after kidney transplantation in adult subjects at increased risk of delayed graft function. …

Last Modified: 02/13/2023 - 21:06

An Expanded Access Phase 2 Study of Sofosbuvir with Ribavirin and with or without Pegylated Interferon for 24 weeks in Subjects who have undergone Liver Transplantation and Who Have Aggressive, Recurrent Hepatitis C infection

… and with or without Pegylated Interferon for 24 weeks in Subjects who have undergone Liver Transplantation and Who …

Last Modified: 02/13/2023 - 21:06

Phase II Open-Label, Single-Center Study Evaluating Safety and Efficacy of Pembrolizumab Following Induction with the Hypomethylating Agent Azacitidine in Patients with Advanced Pancreatic Cancer After Failure of First-Line Therapy

… Induction with the Hypomethylating Agent Azacitidine in Patients with Advanced Pancreatic Cancer After Failure of …

Last Modified: 02/13/2023 - 21:07

Multicenter, Randomized Phase 2B Study to Evaluate the Efficacy, Safety, and Tolerability of OCR-002 (Ornithine Phenylacetate) in Hospitalized Patients with Cirrhosis and Associated Hyperammonemia with an Episode of Hepatic Encephalopathy (STOP-HE)

… hepatic encephalopathy episode requiring hospitalization in cirrhotic patients. Trial Website: … and Tolerability of OCR-002 (Ornithine Phenylacetate) in Hospitalized Patients with Cirrhosis and Associated …

Last Modified: 02/13/2023 - 21:06

Prospective, Multi-Center, Open Label, Pilot Study of Safety and Efficacy of Triple Anti-Viral Therapy with Pegylated Interferon, Ribavirin, and Boceprevir in Patients with Genotype 1 Chronic HCV with End Stage Renal Disease

… pegylated interferon (P-IFN), ribavirin and boceprevir in patients with genotype 1 chronic Hepatitis C Virus (HCV) … with Pegylated Interferon, Ribavirin, and Boceprevir in Patients with Genotype 1 Chronic HCV with End Stage Renal …

Last Modified: 02/13/2023 - 21:06

A Randomized, Double-blind, Placebo-controlled, Dose-ranging, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications in Subjects With Early Decompensated Liver Cirrhosis

… is to assess the efficacy of rifaximin SSD versus placebo in preventing complications of liver cirrhosis, such as … mortality (death due to all causes) or hospitalization, in subjects with early decompensated liver cirrhosis. … is currently marketed as a 550 mg tablet for the reduction in risk of recurrent overt hepatic encephalopathy, a …

Last Modified: 02/13/2023 - 21:06

A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir/Ledipasvir Fixed-Dose Combination + Ribavirin Administered in Subjects Infected with Chronic HCV who have Advanced Liver Disease or are Post-Transplant

… (LDV/SOF) fixed-dose combination (FDC) in participants with chronic genotype 1 or 4 hepatitis C … Fixed-Dose Combination + Ribavirin Administered in Subjects Infected with Chronic HCV who have Advanced Liver …

Last Modified: 02/13/2023 - 21:06

PRO 02/ML28897 MY PATHWAY STUDY: An Open-Label Phase IIA Study Evaluating Trastuzumab/ Pertuzumab, Erlotinib, Vermurafenib, and Vismodegib in Patients Who Have Advanced Solid Tumors with Mutations or Gene Expression Abnormalities Predictive of Response to

… treatment regimens will be evaluated simultaneously in groups of patients who have advanced solid tumors that has … that will convey clinical benefit are not available, and in whom a trial of targeted therapy is considered the best … epidermal growth factor receptor (EGFR), a protein found in increased amounts in certain cancers. EGFR, when …

Last Modified: 02/13/2023 - 21:06

Plastic Surgery Presentations and Research

… the publications below may require subscriptions or a log-in through the Columbia library while PubMed links are … CA, February 1-5, 2019 Levy AS, Lara D, Lin AJ, Rohde CH, Kutler DI, Reeve GS, Spector JA. When in Doubt Take it Out: Functional Restoration of subtotal …

Last Modified: 05/08/2024 - 10:00

How to save money on food

… ways to stretch the dollar on food without coupon cutting: Buy what you need. Careful planning before you head to the grocery store will not only save you time in the store but also money. Plan the recipes you will cook for the week and only purchase what you need. Buy extra. When shelf stable foods go on sale, stock up! Many …

Last Modified: 02/23/2023 - 17:59

Organic or Not?

… To buy organic or not to buy organic? That is the question. At least, that is the question I will attempt to answer for you in this blog. As the organic food sections in our grocery stores continue to expand, you may find …

Last Modified: 02/23/2023 - 17:59

How to Tackle a Farmers Market

… heading to your local market, do some research on what’s in season in your area . Put together a rough list of items you’d like to buy, but stay flexible since you never know what will be … you can use your items while still as fresh as possible. Buy some items that need to be eaten in the next two or three …

Last Modified: 02/23/2023 - 18:00

Pagination

  • « First First page
  • ‹‹ Previous page
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • ›› Next page
  • Last » Last page

Footer About

  • About Us
  • Request an Appointment
  • Virtual Visits
  • Organ Donation
  • Contact Us
  • Subscribe To Our Newsletter

Footer About 2

  • Directory
  • Alumni/JJSS
  • Locations & Directions
  • Ways to Help
  • Disclaimer
FOLLOW US
  • Twitter Logo
  • Facebook Logo
  • Youtube Logo
  • Instagram Logo
Visit
  • New York Presbyterian Logo
  • Columbia University Irving Medical Center Logo

©1999-2026. Columbia University Irving Medical Center, Department of Surgery, New York, NY.